Global Injection Devices for Biological Drugs Market, By Type of Product (Conventional Injection Devices, Others), Application (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Aesthetic Treatment, Other Clinical Applications), End User (Hospitals and Clinics, Home Care Settings, Others), Site of Administration (Skin, Circulatory/Musculoskeletal System, Organs, Central Nervous System), Usability (Reusable Pen Injectors, Disposable Pen Injectors), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Injection Devices for Biological Drugs Market
Injection devices for biological drugs market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 734.35 billion by 2028 growing at a CAGR of 12.58% in the above-mentioned forecast period. The growing awareness among the patients regarding the benefits of biological drugs which will help in boosting the growth of the market.
Injection devices are intended for patients who need regular doses of pharmaceutical drugs and hormones for long-term treatment of diseases such as diabetes, rheumatoid arthritis, and other chronic diseases. Self-injection tools are available in both reusable and disposable types. The self-injection system offers benefits such as minimization of hospital visits, ease of use and low cost.
Surging volume of patients suffering from chronic disorders, increasing prevalence of geriatric population, rising preferences towards self-injection devices, growing prevalence of favourable reimbursement policies of the government, increasing usages of biologics in the pharmaceutical industry are some of the major as well as important factors which will likely to augment the growth of the injection devices for biological drugs market in the projected timeframe of 2021-2028. On the other hand, improving patient compliance along with less stringent regulatory policies and increasing number of technological advancement which will further contribute by generating immense opportunities that will lead to the growth of the injection devices for biological drugs market in the above mentioned projected timeframe.
Introduction of alternative drug delivery methods along with increasing incidence of needlestick injuries and infections which will likely to act as market restraints factor for the growth of the injection devices for biological drugs in the above mentioned projected timeframe. Strict regulation for patent approval which will become the biggest and foremost challenge for the growth of the market.
This injection devices for biological drugs market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on injection devices for biological drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Injection Devices for Biological Drugs Market Scope and Market Size
Injection devices for biological drugs market is segmented on the basis of type of product, application, site of administration, usability, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on type of product, the injection devices for biological drugs market is segmented into conventional injection devices, and others. Conventional injection devices have been further segmented into glass material, and plastic material. Plastic material has been further sub segmented into self-injection devices, needle-free injectors, autoinjectors, pen injectors, wearable injectors, and others.
- Injection devices for biological drugs market has also been segmented based on the end user into hospitals and clinics, home care settings, and others.
- Based on application, the injection devices for biological drugs market is segmented into autoimmune diseases, hormonal disorders, orphan diseases, aesthetic treatment, and other clinical applications. Other clinical applications have been further segmented into pain management, allergies, cancer, hepatitis C, and haemophilia.
- On the basis of site of administration, the injection devices for biological drugs market is segmented into skin, circulatory/musculoskeletal system, organs, and central nervous system. Skin has been further segmented into intradermal, and subcutaneous. Circulatory/musculoskeletal system has been further segmented into intravenous, intracardiac, intramuscular, and intraperitoneal. Organs have been further segmented into intravitreal, and intra-articular. Central nervous system has been further segmented into intracerebral, and intrathecal.
- Based on usability, the injection devices for biological drugs market is segmented into reusable pen injectors, and disposable pen injectors.
Injection Devices for Biological Drugs Market Country Level Analysis
Injection devices for biological drugs market is analysed and market size insights and trends are provided by country, type of product, application, site of administration, usability, and end user as referenced above.
The countries covered in the injection devices for biological drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the injection devices for biological drugs market due to the increasing incidence of chronic diseases along with rising demand of self-injection devices in the region, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2021 to 2028 due to the increasing levels of disposable income, rising occurrences of chronic diseases along with increasing awareness on safety and comfort.
The country section of the injection devices for biological drugs market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Injection devices for biological drugs market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for injection devices for biological drugs market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the injection devices for biological drugs market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Injection Devices for Biological Drugs Market Share Analysis
Injection devices for biological drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to injection devices for biological drugs market.
The major players covered in the injection devices for biological drugs market report are Baxter.; BD; Gerresheimer AG; Pfizer Inc.; SCHOTT AG; Eli Lilly and Company.; Sandoz International GmbH; Terumo Corporation; Teva Pharmaceutical Industries Ltd.; Crossject; Amcor plc; AptarGroup, Inc.; Credence MedSystems, Inc.; West Pharmaceutical Services, Inc.; Ypsomed AG; Consort Medical plc; Antares Pharma Inc.; Sensile Medical AG; SHL Medical AG.; Sanofi; among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
